Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 3 Study of IV to Oral 6-Day Tedizolid Phosphate Compared With 10-day Comparator in Subjects 12 to < 18 Years With cSSTI

Next Previous
Search
Trial Profile

Phase 3 Study of IV to Oral 6-Day Tedizolid Phosphate Compared With 10-day Comparator in Subjects 12 to < 18 Years With cSSTI

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 14 Dec 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tedizolid (Primary) ; Tedizolid (Primary) ; Aztreonam; Cefalexin; Cefalexin; Cefazolin; Cefazolin; Clindamycin; Clindamycin; Flucloxacillin; Flucloxacillin; Linezolid; Linezolid; Metronidazole; Metronidazole; Vancomycin; Vancomycin
  • Indications Abscess; Bacterial infections; Cellulitis; Erysipelas; Gram-negative infections; Gram-positive infections; Skin and soft tissue infections; Wound infections
  • Focus Adverse reactions; Registrational
  • Sponsors Cubist Pharmaceuticals

    • Most Recent Events

    • 21 Mar 2020 Results presented at the 121st Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
    • 03 Oct 2018 Status changed from active, no longer recruiting to completed.
    • 23 Aug 2018 Planned End Date changed from 7 Nov 2018 to 23 Sep 2018.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top